Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

Sam Altman, best known as the CEO of OpenAI, has steadily built a large and diverse investment portfolio that spans ...

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Puma Biotech (PBYI) could be a great choice. It is one of the several stocks that ...

"Under Vision 2030, the Kingdom has emerged as a hub to innovate, invest and build the future breakthroughs that will ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Stellenbosch University (SU) has announced the opening of the LaunchLab Centre for Epidemic Response and Innovation (Ceri) ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 5.61%, which has investors questioning if this is right time to buy ...

LLR Partners has made a growth investment in TruTechnologies, a Research Triangle Park, North Carolina-based provider of real ...

The field of TCR-T therapies is becoming increasingly crowded, with multiple biotechnology companies and pharmaceutical giants investing heavily in this area. TScan faces the risk of being ...

MAIA Biotechnology, Inc.’s MAIA share price has surged by 11.93%, which has investors questioning if this is right time to sell.